Shikiar Asset Management Inc Abb Vie Inc. Transaction History

Shikiar Asset Management Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	SELL	$131.98 - $163.75 $415,736 - $515,812	-3,150 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$106.4 - $120.78 $10,640 - $12,078	100 Added 3.28%	3,150 $340,000
Q2 2021 Jul 16, 2021	BUY	$105.21 - $117.21 $320,890 - $357,490	3,050 New	3,050 $344,000

3,653

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Shikiar Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Shikiar Asset Management Inc with notifications on news.